Related Experiment Video

Updated: Aug 17, 2026

Bioluminescence Imaging of Heme Oxygenase-1 Upregulation in the Gua Sha Procedure
06:39

Bioluminescence Imaging of Heme Oxygenase-1 Upregulation in the Gua Sha Procedure

Published on: August 28, 2009

Heme oxygenase and atherosclerosis

Toshisuke Morita1

  • 1Department of Laboratory Medicine, Toho University School of Medicine, Tokyo, 143-8540, Japan. toshimrt@med.toho-u.ac.jp

Arteriosclerosis, Thrombosis, and Vascular Biology
|July 16, 2005
PubMed

Insights

Heme oxygenase-1 (HO-1) combats oxidative stress in cardiovascular diseases (CVD) by degrading heme and producing antioxidant compounds. HO-1 shows therapeutic potential for treating CVD, including atherosclerosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Reactive oxygen species (ROS) overproduction drives cardiovascular diseases (CVD) like atherosclerosis.
  • Vascular cell-derived ROS regulate inflammatory and antioxidative pathways.
  • Heme oxygenase (HO) is a stress-induced enzyme crucial for heme catabolism.

Purpose of the Study:

  • To explore the role of heme oxygenase (HO) and its inducible form (HO-1) in cardiovascular disease.
  • To review gene-targeting strategies in animal models related to HO-1.
  • To assess the therapeutic potential and challenges of targeting HO-1 for CVD.

Main Methods:

  • Literature review on heme oxygenase and cardiovascular disease.
  • Analysis of studies involving gene-targeting approaches in animal models.
  • Examination of the biochemical mechanisms of HO-1 cytoprotective effects.

Main Results:

  • HO-1 degrades pro-oxidative heme, producing antioxidant biliverdin/bilirubin and anti-inflammatory carbon monoxide.
  • HO-1 products exhibit antioxidant, anti-inflammatory, and vasodilatory properties.
  • Evidence suggests HO-1 plays a protective role against oxidative stress in CVD.

Conclusions:

  • Heme oxygenase-1 (HO-1) is a key adaptive molecule against oxidative stress in cardiovascular diseases.
  • HO-1's cytoprotective mechanisms involve heme degradation and product generation.
  • HO-1 presents a promising therapeutic target for cardiovascular diseases, particularly atherosclerosis.

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...